<p>宾夕法尼亚州巴拉辛伍德，2025 年 6 月 13 日（全球新闻通讯）——Brodsky &amp; Smith 提醒投资者关注以下调查。如果您持有股份并希望讨论该调查，请联系 Jason Brodsky（jbrodsky@brodskysmith.com）或 Marc Ackerman（mackerman@brodskysmith.com），电话 855-576-4847。您无需承担任何费用或财务义务。</p>
<p><strong>CureVac N.V.（纳斯达克 - CVAC）</strong></p>
<p>根据合并协议的条款，CureVac 将被 BioNTech SE（纳斯达克 - BNTX）收购。每股 CureVac 将兑换约 5.46 美元的 BioNTech 美国存托股票，CureVac 的隐含总股本价值约为 12.5 亿美元。交易完成后，CureVac 的股东预计将持有 BioNTech 约 4% 至 6% 的股份。调查关注 CureVac 董事会是否因未能进行公平程序而违反了对股东的信托责任，包括考虑是否为公司的股东提供了公平的价值。</p>
<p>更多信息请访问 https://www.brodskysmith.com/cases/curevac-n-v-nasdaq-cvac/.</p>
<p><strong>Know Labs, Inc.（纽约证券交易所美国 - KNW）</strong></p>
<p>根据协议条款，Know Labs 将被 Goldeneye 1995 LLC（“买方”）收购，买方是金融科技投资者、企业家及前 Ripple 首席风险官 Greg Kidd 的关联公司。买方将收购通过将（i）1,000 个比特币的总和与用于偿还现有债务、赎回未偿还优先股和提供额外营运资金的现金总和相除，得到的公司普通股数量，除以（ii）每股购买价格 0.335 美元。调查关注 Know Labs 董事会是否因未能进行公平程序而违反了对股东的信托责任，包括该交易是否为公司的股东提供了公平的价值。</p>
<p>更多信息请访问 https://www.brodskysmith.com/cases/know-labs-inc-nyse-american-knw/.</p>
<p><strong>Volato Group, Inc.（纽约证券交易所美国 - SOAR）</strong></p>
<p>根据协议条款，Volato Group 将与 M2i Global, Inc.（“M2i Global”）（场外交易 - MTWO）合并。M2i Global 将获得 Volato Group 的普通股，使其持有约 90% 的 Volato 的普通股总数。调查关注 Volato Group 董事会是否因未能进行公平程序而违反了对股东的信托责任，包括合并公司对股东的稀释问题。</p>
<p>更多信息请访问 https://www.brodskysmith.com/cases/volato-group-inc-nyse-american-soar/.</p>
<p><strong>Heliogen, Inc.（场外交易 - HLGN）</strong></p>
<p>根据合并协议的条款，Heliogen 将被 Zeo Energy Corp.（“Zeo Energy”）收购。交易完成后，Heliogen 的证券持有人将根据 Zeo Class A 普通股的每股价格 1.5859 美元，获得总值约 1000 万美元的 Zeo Class A 普通股，并根据交易完成时 Heliogen 的净现金情况进行调整。调查关注 Heliogen 董事会是否因未能进行公平程序而违反了对股东的信托责任，包括考虑是否为公司的股东提供了公平的价值。</p>
<p>更多信息请访问 https://www.brodskysmith.com/cases/heliogen-inc-otc-hlgn/.</p>
<p>Brodsky &amp; Smith 是一家诉讼律师事务所，拥有丰富的经验，代表全国各地的股东进行证券和集体诉讼。Brodsky &amp; Smith 的律师已被全国多个法院任命为集体诉讼的首席律师，并成功为我们的客户和股东追回了数百万美元。律师广告。以往的结果并不保证类似的结果。</p>

HLGN

SOAR

CVAC

USBC

<p>Brodsky & Smith 正在通知投资者有关对几家公司进行调查的情况，调查内容涉及其董事会在收购过程中可能违反受托责任。这些公司包括 CureVac N.V.、Know Labs, Inc.、Volato Group, Inc. 和 Heliogen, Inc. 每项调查的重点是董事会是否进行了公平的程序，并在各自的合并协议中为股东提供了公平的价值。投资者可以联系 Brodsky & Smith 获取更多信息，无需承担任何财务义务</p>

<p>BALA CYNWYD, Pa., June 13, 2025 (GLOBE NEWSWIRE) — Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.</p>
<div class="lb-trans"><p>宾夕法尼亚州巴拉辛伍德，2025 年 6 月 13 日（全球新闻通讯）——Brodsky &amp; Smith 提醒投资者关注以下调查。如果您持有股份并希望讨论该调查，请联系 Jason Brodsky（jbrodsky@brodskysmith.com）或 Marc Ackerman（mackerman@brodskysmith.com），电话 855-576-4847。您无需承担任何费用或财务义务。</p>
</div><p><strong>CureVac N.V. (Nasdaq - CVAC)</strong></p>
<div class="lb-trans"><p><strong>CureVac N.V.（纳斯达克 - CVAC）</strong></p>
</div><p>Under the terms of the Merger Agreement, CureVac will be acquired by BioNTech SE (Nasdaq – BNTX). Each CureVac share will be exchanged for approx. $5.46 in BioNTech ADSs, resulting in an implied aggregate equity value for CureVac of approx. $1.25 billion. Upon closing of the transaction, CureVac shareholders are expected to own between 4% and 6% of BioNTech. The investigation concerns whether the CureVac Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company’s shareholders.</p>
<div class="lb-trans"><p>根据合并协议的条款，CureVac 将被 BioNTech SE（纳斯达克 - BNTX）收购。每股 CureVac 将兑换约 5.46 美元的 BioNTech 美国存托股票，CureVac 的隐含总股本价值约为 12.5 亿美元。交易完成后，CureVac 的股东预计将持有 BioNTech 约 4% 至 6% 的股份。调查关注 CureVac 董事会是否因未能进行公平程序而违反了对股东的信托责任，包括考虑是否为公司的股东提供了公平的价值。</p>
</div><p>Additional information can be found at https://www.brodskysmith.com/cases/curevac-n-v-nasdaq-cvac/.</p>
<div class="lb-trans"><p>更多信息请访问 https://www.brodskysmith.com/cases/curevac-n-v-nasdaq-cvac/.</p>
</div><p><strong>Know Labs, Inc. (NYSE American - KNW)</strong></p>
<div class="lb-trans"><p><strong>Know Labs, Inc.（纽约证券交易所美国 - KNW）</strong></p>
</div><p>Under the terms of the agreement, Know Labs will be acquired by Goldeneye 1995 LLC (“Buyer”), an affiliate of fintech investor, entrepreneur, and former Ripple Chief Risk Officer, Greg Kidd. Buyer will acquire that number of shares of the Company’s common stock obtained by dividing (i) the sum of 1,000 Bitcoin and a cash sum to retire existing debt, redeem outstanding preferred equity and provide additional working capital, by (ii) the per share purchase price of $0.335. The investigation concerns whether the Know Labs Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal provides fair value to the Company’s shareholders.</p>
<div class="lb-trans"><p>根据协议条款，Know Labs 将被 Goldeneye 1995 LLC（“买方”）收购，买方是金融科技投资者、企业家及前 Ripple 首席风险官 Greg Kidd 的关联公司。买方将收购通过将（i）1,000 个比特币的总和与用于偿还现有债务、赎回未偿还优先股和提供额外营运资金的现金总和相除，得到的公司普通股数量，除以（ii）每股购买价格 0.335 美元。调查关注 Know Labs 董事会是否因未能进行公平程序而违反了对股东的信托责任，包括该交易是否为公司的股东提供了公平的价值。</p>
</div><p>Additional information can be found at https://www.brodskysmith.com/cases/know-labs-inc-nyse-american-knw/.</p>
<div class="lb-trans"><p>更多信息请访问 https://www.brodskysmith.com/cases/know-labs-inc-nyse-american-knw/.</p>
</div><p><strong>Volato Group, Inc. (NYSE American - SOAR)</strong></p>
<div class="lb-trans"><p><strong>Volato Group, Inc.（纽约证券交易所美国 - SOAR）</strong></p>
</div><p>Under the terms of the agreement, Volato Group will merge with M2i Global, Inc. (“M2i Global”) (OTC - MTWO). M2i Global will receive common shares of Volato Group stock such that M2i Global will own approximately 90% of the total shares of common stock of Volato. The investigation concerns whether the Volato Group Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company.</p>
<div class="lb-trans"><p>根据协议条款，Volato Group 将与 M2i Global, Inc.（“M2i Global”）（场外交易 - MTWO）合并。M2i Global 将获得 Volato Group 的普通股，使其持有约 90% 的 Volato 的普通股总数。调查关注 Volato Group 董事会是否因未能进行公平程序而违反了对股东的信托责任，包括合并公司对股东的稀释问题。</p>
</div><p>Additional information can be found at https://www.brodskysmith.com/cases/volato-group-inc-nyse-american-soar/.</p>
<div class="lb-trans"><p>更多信息请访问 https://www.brodskysmith.com/cases/volato-group-inc-nyse-american-soar/.</p>
</div><p><strong>Heliogen, Inc. (OTC - HLGN)</strong></p>
<div class="lb-trans"><p><strong>Heliogen, Inc.（场外交易 - HLGN）</strong></p>
</div><p>Under the terms of the Merger Agreement, Heliogen will be acquired by Zeo Energy Corp.  (“Zeo Energy”). Upon the closing of the transaction, Heliogen’s securityholders will receive shares of Zeo’s Class A common stock valued at approximately $10 million in the aggregate, based on a Zeo Class A common stock price of $1.5859 per share, and subject to an adjustment mechanism based on Heliogen’s net cash at the closing. The investigation concerns whether the Heliogen Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company’s shareholders.</p>
<div class="lb-trans"><p>根据合并协议的条款，Heliogen 将被 Zeo Energy Corp.（“Zeo Energy”）收购。交易完成后，Heliogen 的证券持有人将根据 Zeo Class A 普通股的每股价格 1.5859 美元，获得总值约 1000 万美元的 Zeo Class A 普通股，并根据交易完成时 Heliogen 的净现金情况进行调整。调查关注 Heliogen 董事会是否因未能进行公平程序而违反了对股东的信托责任，包括考虑是否为公司的股东提供了公平的价值。</p>
</div><p>Additional information can be found at . https://www.brodskysmith.com/cases/heliogen-inc-otc-hlgn/,</p>
<div class="lb-trans"><p>更多信息请访问 https://www.brodskysmith.com/cases/heliogen-inc-otc-hlgn/.</p>
</div><p>Brodsky &amp; Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky &amp; Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>Brodsky &amp; Smith 是一家诉讼律师事务所，拥有丰富的经验，代表全国各地的股东进行证券和集体诉讼。Brodsky &amp; Smith 的律师已被全国多个法院任命为集体诉讼的首席律师，并成功为我们的客户和股东追回了数百万美元。律师广告。以往的结果并不保证类似的结果。</p>
</div>

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)

GlobeNewswire

Heliogen

Volato

CureVac BV

Know Labs

BRODSKY & SMITH 股东更新：通知投资者关于以下公司的调查：CureVac N.V.（纳斯达克 - CVAC）、Know Labs, Inc.（纽约证券交易所美国市场 - KNW）、Volato Group, Inc.（纽约证券交易所美国市场 - SOAR）、Heliogen, Inc.（场外交易市场 - HLGN）